Development of novel drug delivery systems for targeted cancer therapy

Thesis Overview

The project "Development of novel drug delivery systems for targeted cancer therapy" aims to address the pressing need for more effective and precise treatments for cancer. Cancer remains a major health concern worldwide, with existing treatment options often causing significant side effects and limited efficacy due to their non-specific nature. Targeted drug delivery systems offer a promising approach to improve cancer treatment by delivering therapeutic agents directly to cancer cells while minimizing damage to healthy tissues. The research will focus on developing innovative drug delivery systems that can specifically target cancer cells, enhancing treatment efficacy and reducing adverse effects. Various types of drug delivery systems will be explored, including nanoparticles, liposomes, and micelles, which can be designed to carry anticancer drugs and release them selectively within the tumor microenvironment. These systems can be engineered to exploit the unique characteristics of cancer cells, such as overexpressed receptors or enzymes, for targeted delivery. The project will involve an in-depth investigation of the design, synthesis, and characterization of novel drug delivery systems, evaluating their ability to efficiently deliver drugs to cancer cells in preclinical models. The research will also assess the safety, pharmacokinetics, and therapeutic efficacy of these systems compared to conventional drug formulations. Furthermore, the study will explore the potential of combining targeted drug delivery systems with other treatment modalities, such as immunotherapy or gene therapy, to enhance the overall anticancer effect. By integrating multiple therapeutic strategies, the project aims to develop comprehensive and personalized approaches for cancer treatment. Overall, the research on the development of novel drug delivery systems for targeted cancer therapy holds great promise in revolutionizing cancer treatment by improving drug efficacy, reducing side effects, and ultimately enhancing patient outcomes. The findings of this study have the potential to significantly impact the field of oncology and pave the way for the development of more effective and personalized cancer therapies.